Implantable Cardioverter-Defibrillators in Trials of Drug Therapy for Heart Failure

BACKGROUND Medical therapy for heart failure with reduced ejection fraction evolved since trials validated the use of implantable cardioverter-defibrillators (ICDs). We sought to evaluate the performance of ICDs in reducing mortality in the era of modern medical therapy by means of a systematic revi...

ver descrição completa

Detalhes bibliográficos
Autor principal: Gama, Francisco (author)
Outros Autores: Ferreira, Jorge (author), Carmo, João (author), Costa, Francisco Moscoso (author), Carvalho, Salomé (author), Carmo, Pedro (author), Cavaco, Diogo (author), Morgado, Francisco Belo (author), Adragão, Pedro (author), Mendes, Miguel (author)
Formato: article
Idioma:eng
Publicado em: 2020
Assuntos:
all‐cause mortality
heart failure with reduced ejection fraction
implantable cardioverter–defibrillators
sudden cardiac death
Cardiology and Cardiovascular Medicine
Texto completo:http://hdl.handle.net/10362/104066
País:Portugal
Oai:oai:run.unl.pt:10362/104066

Texto Completo

http://hdl.handle.net/10362/104066

Registos relacionados